Executives
-
Robert B. FordChairman of the Board and Chief Executive Officer -
Robert E. Funck Jr.Executive Vice President -
Philip P. BoudreauSenior Vice President -
Hubert L. AllenExecutive Vice President -
Lisa D. EarnhardtExecutive Vice President and Group President -
Daniel G. SalvadoriExecutive Vice President and Group President -
Allen Hubert LEXECUTIVE VICE PRESIDENT -
Ford Robert BCHAIRMAN AND CEO
-
Boudreau Philip PEXECUTIVE VICE PRESIDENT
-
Mccoy John A. Jr.VICE PRESIDENT
-
Morrone Louis H.EXECUTIVE VICE PRESIDENT
-
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENT
-
Earnhardt Lisa DEXECUTIVE VICE PRESIDENT
-
Wainer Andrea FEXECUTIVE VICE PRESIDENT
-
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENT
-
Moreland Mary KEXECUTIVE VICE PRESIDENT
Board Directors
-
R. J. AlpernDirector
-
C. Babineaux-FontenotDirector
-
S. E. BlountDirector
-
P. GonzalezDirector
-
M. A. KumbierDirector
-
D. W. McDewDirector
-
N. McKinstryDirector
-
M. G. OGradyDirector
-
W. A. OsbornDirector
-
M. F. RomanDirector
-
D. J. StarksDirector
-
J. G. StrattonDirector
-
G. F. TiltonDirector
-
Stratton John GDirector
-
Roman Michael FDirector
-
Gonzalez Patricia PaolaDirector
-
Alpern Robert JDirector
-
Starks Daniel JDirector
-
O'Grady MichaelDirector
-
Mckinstry NancyDirector
-
Mcdew Darren WDirector
-
Kumbier MichelleDirector
-
Blount Sally E.Director
-
Babineaux-Fontenot ClaireDirector
?
Allen Hubert L
EXECUTIVE VICE PRESIDENT
Abbott Laboratories
US, North Chicago [HQ]
CIK
1565916
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
185,659
Price per Share :
$113.91
Equivalence :
$21,148,416.69
Transaction History
-
F185,659 Shares After TransactionValue : $22,288,362.95$986,090.70Transaction Date : 02/29/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
S184,806 Shares After TransactionValue : $21,899,511.00Sold $101,080.50Transaction Date : 03/01/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
M342,227 Shares After TransactionValue : $16,084,669.00$7,398,787.00Transaction Date : 10/21/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.68 to $118.92, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.68 to $118.59, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.#3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.68 to $117.64, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
-
S340,978 Shares After TransactionValue : $40,511,596.18Sold $148,393.69Transaction Date : 10/21/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.68 to $118.92, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.68 to $118.59, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.#3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.68 to $117.64, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
-
S335,077 Shares After TransactionValue : $39,589,347.55Sold $697,203.15Transaction Date : 10/21/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.68 to $118.92, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.68 to $118.59, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.#3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.68 to $117.64, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.